ARCHIVES

Zydelig Tablets Approved For Three Blood Cancers

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows

August 28, 2009

Radiation, Tamoxifen After Surgery Reduce Breast Cancer Occurrence

March 25, 2011

FDA, Clinical Investigators Head Or Showdown Over Demand To See Individual Patient Records

April 18, 1980

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985